HY-126077-50mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-18169-10mg
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7]
|
|
COVID-19-immunoregulation
|
|
HY-18169-5mg
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7]
|
|
COVID-19-immunoregulation
|
|
HY-18169-1mL
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-W403075-20mg
|
MedChemexpress LLC
|
N-(3-Methoxybenzyl)stearamide [CAS 1429659-99-3]
|
|
COVID-19-immunoregulation
|
|
HY-101854-10mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-100mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-200mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-5mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-50mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-1mL
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-14984-10mg
|
MedChemexpress LLC
|
N6022 [CAS 1208315-24-5]
|
|
COVID-19-immunoregulation
|
|
HY-14984-100mg
|
MedChemexpress LLC
|
N6022 [CAS 1208315-24-5]
|
|
COVID-19-immunoregulation
|
|
HY-14984-5mg
|
MedChemexpress LLC
|
N6022 [CAS 1208315-24-5]
|
|
COVID-19-immunoregulation
|
|
HY-14984-50mg
|
MedChemexpress LLC
|
N6022 [CAS 1208315-24-5]
|
|
COVID-19-immunoregulation
|
|
HY-14984-1mL
|
MedChemexpress LLC
|
N6022 [CAS 1208315-24-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B0391-1g
|
MedChemexpress LLC
|
Naftopidil [CAS 57149-07-2]
|
|
COVID-19-immunoregulation
|
|
HY-B0391-10g
|
MedChemexpress LLC
|
Naftopidil [CAS 57149-07-2]
|
|
COVID-19-immunoregulation
|
|
HY-B0391-5g
|
MedChemexpress LLC
|
Naftopidil [CAS 57149-07-2]
|
|
COVID-19-immunoregulation
|
|
HY-B0391-500mg
|
MedChemexpress LLC
|
Naftopidil [CAS 57149-07-2]
|
|
COVID-19-immunoregulation
|
|
HY-B0391-1mL
|
MedChemexpress LLC
|
Naftopidil [CAS 57149-07-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-101011-5mg
|
MedChemexpress LLC
|
Naloxonazine (dihydrochloride) [CAS 880759-65-9]
|
|
COVID-19-immunoregulation
|
|
HY-B0446-1g
|
MedChemexpress LLC
|
Naphazoline (hydrochloride) [CAS 550-99-2]
|
|
COVID-19-immunoregulation
|
|
HY-B0446-10g
|
MedChemexpress LLC
|
Naphazoline (hydrochloride) [CAS 550-99-2]
|
|
COVID-19-immunoregulation
|
|
HY-B0446-5g
|
MedChemexpress LLC
|
Naphazoline (hydrochloride) [CAS 550-99-2]
|
|
COVID-19-immunoregulation
|
|